Archived article. This article was published by Synergus RWE on 12 Apr 2016 and is kept for reference. For current insights visit athagoras Medtech.
Health technology assessments of in-vitro diagnostic tests
This study revealed similarities in evidence requirements for in-vitro diagnostic tests in health technology assessments in England and France. However, economic evidence is not a part of French assessments of new codes for biological tests and a mandatory part of Diagnostic Assessment Programme at NICE in England. Analysis of factors, which can influence recommendations of health technology assessments is provided. Good diagnostic performance, high level of evidence, supportive opinion of experts and cost-effectiveness of the test were among the most common factors of positive recommendations.